Oxcarbazepine: all 44 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedNCT03695094Phase 1Results posted
• Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedNCT03689114Phase 4Results posted
• Characterization of Epilepsy Patients BEEP 2bCompletedNCT02707965Phase 1Results posted
• Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar DisorderCompletedNCT02456896Phase 4Results posted
• Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)TerminatedNCT01891890Phase 3Results posted
• Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedNCT01679002Phase 1Results posted
• Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedNCT01678976Phase 1Results posted
• Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedNCT00975715Phase 2/3Results posted
• Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyCompletedNCT00908349Phase 3Results posted
• Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and OxcarbazepineCompletedNCT00900237Phase 1Results posted
• Oxcarbazepine 600 mg Tablets Under Fasting ConditionsCompletedNCT00850174Phase 1Results posted
• Oxcarbazepine 600 mg Tablets Under Non-Fasting ConditionsCompletedNCT00849797Phase 1Results posted
• Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial SeizuresCompletedNCT00772603Phase 3Results posted
• Oxcarbazepine Versus Placebo in Childhood AutismCompletedNCT00467753Not applicableResults posted
• Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal NeuralgiaActive, not recruitingNCT07252453Not applicable
• Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal NeuralgiaActive, not recruitingNCT06849219Phase 4
• Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical TrialStatus unknownNCT04996199Phase 4
• Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal NeuralgiaWithdrawnNCT03374709Phase 4
• Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal SeizuresCompletedNCT02705768Phase 4
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness StudyWithdrawnNCT02219373Phase 3
• Symptom Based Treatment of Neuropathic PainCompletedNCT02180880Phase 4
• Protective Role of Oxcarbazepine in Multiple SclerosisCompletedNCT02104661Phase 2
• Oxcarbazepine Plus Morphine in Patients With Refractory Cancer PainTerminatedNCT02078089Phase 1
• Comparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaStatus unknownNCT01893229Phase 4
• Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed ConditionsCompletedNCT01703468Phase 1
• Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted ConditionsCompletedNCT01702623Phase 1
• Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic PainCompletedNCT01302275Phase 4
• Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedNCT01051193Phase 2/3
• Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed ConditionCompletedNCT00951847Not applicable
• Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting ConditionsCompletedNCT00951600Not applicable
• Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy PatientsCompletedNCT00918047Phase 1
• Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute SchizophreniaCompletedNCT00637234Phase 2/3
• Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNCT00618046Not applicable
• Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNCT00616863Not applicable
• Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting ConditionsCompletedNCT00616681Not applicable
• Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial SeizuresCompletedNCT00275925Phase 4
• Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial SeizuresCompletedNCT00275912Phase 4
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.CompletedNCT00154362Phase 4
• The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedNCT00154323Phase 4
• The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)CompletedNCT00145691Phase 3
• Study of Efficacy of Oxcarbazepine in Therapy of Bronchial AsthmaCompletedNCT00142025Phase 4
• Pediatric Epilepsy StudyCompletedNCT00050947Phase 3
• Pediatric Epilepsy StudyCompletedNCT00050934Phase 3

← Oxcarbazepine overview